lol
Now you can imagine this case going to appeal, appeal might rule in amrn's favor for procedural error and remanded for reconsideration, Judge Du finds a new way to pronounce "fish oil", another appeal... maybe adding up to 2-5 years of patent litigation, plausibly? Hikma and Reddy gonna hate how orange FDA's book is.
Amarin may just manage to litigate its way to exclusivity. Not ideal, but rough justice. Before this week I was wholeheartedly in favor of JT holding out for the golden BO. Now I feel like he should be ready to accept half of whatever target price he was wanting before. Most stocks are down big just for existing these days.